Journal Mobile Options
Table of Contents
Vol. 11, No. 3, 2001
Issue release date: April 2001

Prestroke Dementia

Barba R. · Castro M.D. · del Mar Morín M. · Rodriguez-Romero R. · Rodríguez-García E. · Cantón R. · Del Ser T.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Objective: To determine the frequency, associated factors and outcome of dementia previous to a stroke. Design: Cross-sectional study of a cohort of 324 consecutive unselected stroke patients (mean age 70.9 years, range 20–98; 255 ischaemic, 46 haemorrhagic and 25 indefinite). Methods: Cognitive and functional status prior to stroke were assessed by means of an interview to a relative, a short version of the Informant Questionnaire on Cognitive Decline in the Elderly and the Barthel Index. The DSM-III-R criteria were used to establish the diagnosis of prestroke dementia. Clinical and CT features of patients with and without prestroke dementia were compared. Results: Forty-nine patients (15%) were demented before stroke; they were significantly older, less well educated, they had more frequently female gender, prior cerebrovascular disease, cerebral and medial temporal lobe atrophy and leukoaraiosis in the CT scan, and they had a higher mortality rate. Female sex (OR 3.7, CI 95% 1.2–12), low education (OR 2.1, CI 95% 1.1–4.2), previous stroke (OR 3.6, CI 95% 1.2–11), and cerebral atrophy (OR 3.8, CI 95% 1.7–8.3) were independently associated with prestroke dementia in the logistic regression analysis. Conclusions: Fifteen percent of stroke patients have prestroke dementia and they have a worse outcome. Factors associated with prestroke dementia are reminiscent both of degenerative and vascular brain pathology.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Censori B, Manara O, Agostinis C, Camerlingo M, Casto L, Galavotti B, Partziguian T, Servalli MC, Cesana B, Belloni G, Mamoli A: Dementia after first stroke. Stroke 1996;27:1205–1210.
  2. Inzitari D, Di Carlo A, Pracucci G, Lamassa M, Vanni P, Romanelli M, Spolveri S, Adriani P, Meucci I, Landini G, Ghetti A: Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry. Stroke 1998;29:2087–2093.
  3. Pohjasvaara T, Erkinjuntti T, Ylikoski R, Hietanen M, Vataja R, Kaste M: Clinical determinants of poststroke dementia. Stroke 1998;29:75–81.
  4. Tatemichi TK, Desmond DW, Mayeux R, Paik M, Stern Y, Sano M, Remien RH, Williams JB, Mohr JP, Hauser WA: Dementia after stroke: Baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 1992;42:1185–1193.
  5. Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA: Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 1990;21:858–866.
  6. Pohjasvaara T, Mantyla R, Aronen HJ, Leskela M, Salonen O, Kaste M, Erkinjuntti T: Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort. J Neurol Neurosurg Psychiatry 1999;67:742–748.
  7. Hénon H, Pasquier F, Durieu I, Godefroy O, Lucas C, Lebert F, Leys D: Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997;28:2429–2436.
  8. Andersen G, Vestergaard K, Riis JO, Ingemen-Nielsen M: Intellectual impairment in the first year following stroke compared to an age-matched population sample. Cerebrovasc Dis 1996;6:363–369.
  9. Kokmen E, Whisnant JP, O`Fallon WM, Chu CP, Beard CM: Dementia after ischemic stroke. Neurology 1996;19:154–159.
  10. Classification of Cerebrovascular Diseases III: Ad Hoc Committee of NINDS. Stroke 1990;21:637–676.
  11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
  12. Mahoney FI, Barthel DW: Functional Evaluation: The Barthel Index. Md State Med J 1965;15:61–65.
  13. Morales JM, González-Montalvo JI, Bermejo F, Del-Ser T: The screening of mild dementia with a shortened Spanish version of the ’Informant Questionnaire on Cognitive Decline in the Elderly’. Alzheimer Dis Assoc Disord 1995;9:105–111.
  14. Del Ser T, Morales JM, Barquero MS, Cantón R, Bermejo F: Application of a Spanish version of the ’Informant Questionnaire on Cognitive Decline in the Elderly’ in the clinical assessment of dementia. Alzheimer Dis Assoc Disord 1997;11:3–8.
  15. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V: The Canadian Neurological Scale: Validation an reliability assessment. Neurology 1989;39:638–643.
  16. Pfeiffer E: A short portable mental status questionnarie for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433–441.
  17. Castillo V, Bogousslavsky J: Early classification of stroke. Cerebrovasc Dis 1997;7(suppl 3):5–11.
  18. Leys D, Pruvo JP, Petit H, Gaudet Y, Clarisse J: Maladie d`Alzheimer: analyse statistique des resultats du scanner X. Rev Neurol (Paris) 1989;145:134–139.

    External Resources

  19. Aharon-Peretz J, Cummings JL, Hill MA: Vascular dementia and dementia or Alzheimer type: Cognition, ventricular size and leukoaraiosis. Arch Neurol 1988;45:719–721.

    External Resources

  20. Jobst KA, Smith AD, Szatmari M, Molyneux A, Erisi ME, King E, Smith A, Jakowaaski A, McDonald B, Wald N: Detection in life of confirmed Alzheimer`s disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340:1179–1183.
  21. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3 rev. Washington, American Psychiatric Association, 1987.
  22. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A: Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250–260.
  23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
  24. Cox DR: Regression models and life tables. J R Stat Soc B 1972;34:187–220.
  25. SPSS: Statistical Package for Social Sciences; Windows Version 7.5. Chicago, SPSS, 1997.
  26. Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R: Risk of dementia after stroke in a hospitalised cohort: Results of a longitudinal study. Neurology 1994;44:1885–1891.
  27. Jorm AF: A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Development and cross-validation. Psychol Med 1994;24:145–153.
  28. Woo JI, Kim JH, Lee JH: Age of onset and brain atrophy in Alzheimer’s disease. Int Psychogeriatr 1997;9:183–196.
  29. Arai H, Kobayashi K, Ikeda K, Nagao Y, Ogihara R, Kosaka K: A computed tomography study of Alzheimer’s disease. J Neurol 1983;229:69–77.

    External Resources

  30. Hubbard BM, Anderson JM: A quantitative study of cerebral atrophy in old age and senile dementia. J Neurol Sci 1981;50:135–145.
  31. Erkinjuntti T, Ketonen L, Sulkava R, Vuorialho M, Palo J: CT in the differential diagnosis between Alzheimer’s disease and vascular dementia. Acta Neurol Scand 1987;75:262–270.
  32. Katzman R: Education and the prevalence of dementia and Alzheimer`s disease. Neurology 1993;43:13–20.
  33. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, Hofman A: Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam Study. BMJ 1995;310:970–973.
  34. Breteler MM, Claus JJ, Grobbee DE, Hofman A: Cardiovascular disease and distribution of cognitive function in elderly people: The Rotterdam Study. BMJ 1994;308:1604–1608.
  35. Del Ser T, Hachinski V, Merskey H, Muñoz DG: An autopsy-verified study of the effect of education on degenerative dementia. Brain 1999;122:2309–2319.

    External Resources

  36. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF: Cerebral infarcts in patients with autopsy-proven Alzheimer’s disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer’s Disease. Neurology 1998;51:159–162.
  37. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 1997;277:813–817.
  38. Rockwood K, Ebly E, Hachinski V, Hogan D: Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol 1997;54:33–39.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50